This is an old revision of this page, as edited by CheMoBot(talk | contribs) at 22:37, 3 January 2012(Updating {{chembox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'CASNo_Ref') per Chem/Drugbox validation (report [[Wikipedia_talk:WikiProject_Chemicals|er...). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 22:37, 3 January 2012 by CheMoBot(talk | contribs)(Updating {{chembox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'CASNo_Ref') per Chem/Drugbox validation (report [[Wikipedia_talk:WikiProject_Chemicals|er...)
GV (IUPAC name: 2-(Dimethylamino)ethyl N,N-dimethylphosphoramidofluoridate) is an organophosphatenerve agent. GV is a part of a new series of nerve agents with properties similar to both the "G-series" and "V-series". It is a potent acetylcholinesterase inhibitor with properties similar to other nerve agents, being a highly poisonous vapour. Treatment for poisoning with GV involves drugs such as atropine, benactyzine, obidoxime and HI-6.[1][2]
References
^Fusek J, Bajgar J. Treatment of intoxication with GV compound in laboratory rats. Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity v Hradci Kralove. 1994;37(2):57-62. PMID 7784799
^Kassa J, Bajgar J. Therapeutic efficacy of obidoxime or HI-6 with atropine against intoxication with some nerve agents in mice. Acta Medica (Hradec Kralove). 1996;39(1):27-30. PMID 9106387